explore -WSS

explore

author：explore 2025-08-12 09:08:45 - browse：7311

Garry Tan, CEO of Y Combinator Seb Daly/Web Summi

WASHINGTON — In San Francisco, Y Combinator’s firebrand chief executive Garry Tan is one of the startup economy’s most recognizable figures. Well before he became the leader of the coveted startup accelerator that bred global brands like Airbnb, Stripe and OpenAI, Tan was a self-made founder who sold his own company to Twitter.

But here in the nation’s political capital, Tan is far less known. He’s hoping to grow his influence here, offering up his vast network of founders as a source of expertise for regulators struggling to wrap their heads around new technologies like artificial intelligence and how best to rein it in.

“We’re happy to be a phone-a-friend for people who are trying to understand tech,” he told the Economic Club of Washington recently when asked how he’d measure success during Y Combinator’s first-ever policy-focused visit. “‘Little tech’ represents competition, and consumer choice,” he said later at a separate event in a dimly lit Senate room filled with a few dozen Congressional staffers.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Biden declares emergency in flood

WSS

FDA has safety concerns on CRISPR

Create a giant ice tray with this foil pan hack to keep food cold this summer

Swim instructor mom warns parents not to buy blue swimsuits for kids

An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

The aspartame in Diet Coke probably isn’t giving you cancer

FDA has safety concerns on CRISPR

hotspot

explore

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

focus

Activists slam private health insurers over coverage restrictions

Eisai exec who led development of Alzheimer’s drug to retire

Apple is now the first public company to be valued at $3 trillion

Rikers Island jail violence not addressed, NYC should be held in contempt: Fed monitor

Peter Hotez and the public health issue of online harassment

The U.S. needs a new definition of substance use “recovery”

State Dept. review finds Biden bears some blame for Afghanistan failures

Medicare wants to send $9 billion to 340B hospitals

Drug repurposing or repositioning? The language matters

Physician subsidies by hospitals soar in wake of No Surprises Act

focus

The aspartame in Diet Coke probably isn’t giving you cancer

Biden targets hefty hospital 'facility fees' that often surprise patients

The aspartame in Diet Coke probably isn’t giving you cancer

Maker of FluMist seeks to allow at

Bank of America ordered to pay more than $100 million for double charging fees, withholding rewards

WHO may add ‘noma' to its list of neglected tropical diseases

Wikipedia

hotspot

explore

focus